The United States has passed yet another grim milestone in its battle to contain Covid-19 with the number of cases now above the five million mark. While some countries such as New Zealand have successfully suppressed the pandemic, a vaccine now appears to be the only hope for much of humanity in breaking chains of infection and restoring some semblance of normality. When he was testifying before Congress, Dr. Fauci, America’s top expert on infectious diseases, said he was optimistic a vaccine would be ready by early 2021.
Liquidity moves markets!Follow the money. Find the profits!
Even if that happens, a large swathe of the American population would be unwilling to take it, according to a new Gallup poll. Conducted between July 20 and August 02, it found that more than a third of U.S. adults would be unwilling to take an FDA approved Covid-19 vaccine at no cost. It also recorded a considerable partisan divide in attitudes with 81 percent of Democrats indicating they would be willing to get vaccinated while 53 percent of Republicans said they would be unwilling. Broken down by age, 76 percent of Americans aged between 18 and 29 said they would take a vaccine, along with 70 percent of senior citizens, while reluctance levels are highest among middle aged people.
This chart shows the share of U.S. adults willing to get an FDA approved, no cost vaccine for Covid-19.
Wall Street Examiner Disclosure: Lee Adler, The Wall Street Examiner reposts third party content with the permission of the publisher. The opinions expressed in these reposts are not those of the Wall Street Examiner or Lee Adler, unless authored by me, under my byline. I curate posts here on the basis of whether they represent an interesting and logical point of view, that may or may not agree with my own views. Some of the content includes the original publisher's promotional messages. No endorsement of such content is either expressed or implied by posting the content. All items published here are matters of information and opinion, and are neither intended as, nor should you construe it as, individual investment advice. Do your own due diligence when considering the offerings of information providers, or considering any investment.